We narrowed to 760 results for: Dos

CRISPR plasmids that have been designed for use in yeast.

Addgene's interviews Chris Voigt of MIT about the intersection of CRISPR and synthetic biology and his new work building circuits with CRISPRs.

Interview with Nicola Patron about her work in plant synthetic biology and her Golden Gate MoClo plasmid kit.

Addgenie Emma Markham describes her winding career path and provides advice on how you can find a great job after undergrad.

Addgene welcomes Julie Cicalese, former Chief Human Resource Officer for Harvard Medical School, to the Board of Directors.

Learn about science writing in this post of our careers in science communication series.

What is a career coach and how can scientists find the right one for them?

CRISPR plasmids based on Cas13 designed to precisely edit RNA targets.

CRISPR plasmids that have been designed for use in Drosophila and other insects.

Get an inside look into the software development process. at Addgene.

Leaving the lab bench for a career outside of academic research can be a daunting task! In this blog post, we describe some ways to ease the transition from bench science to the office.

Addgene Outreach Scientist Klaus Wanisch provides us with all the details on a science careers in technical support.

Learn how the team building atmosphere at Addgene keeps its employees excited about helping researchers share their science.

Five steps to executing a great panel discussion - from planning to moderator control to audience participation.

The co-founders of Revolution Bioengineering, aka RevBio, share the story of how they chose to leave academia and start a synthetic biology company.

CRISPR plasmids for targeted epigenetic modification, including histone acetylation/demethylation, and cytosine methylation/demethylation.

CRISPR expression plasmids that have been designed for use in plants.

Meet Addgene's Newest Board Member Bart Newland.

Learn about how to identify and develop creativity in the lab - a skill that's valuable in and out of the sciences!

Drew Endy discusses the Biobrick Public Agreement (BPA) Plasmid Collection, BIL gates, BIOFAB, and the future of the bioeconomy.